Vimta Labs Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vimta Labs Limited with three other
miscellaneous service companies in Asia:
Japan Tissue Engineering Company Limited
sales of 2.27 billion Japanese Yen [US$20.24 million]
of which 61%
was Regenerative Medicine Products Business),
Gene Techno Science Co Ltd
(1.06 billion Japanese Yen [US$9.44 million]
Trans Genic Inc
based in Japan
(3.60 billion Japanese Yen [US$32.09 million]
of which 42%
was TGBS business).
During the year ended March of 2018, sales at
Vimta Labs Limited were 1.81 billion Indian Rupees (US$24.65 million).
increase of 18.1%
versus 2017, when the company's sales were 1.53 billion Indian Rupees.
This was the third consecutive year of growth at Vimta Labs Limited.